Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Medical and Economical Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases

Next Previous
X
Search
Trial Profile

Medical and Economical Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 18 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bevacizumab (Primary) ; Sulfur hexafluoride (Primary)
  • Indications Colorectal cancer; Liver metastases
  • Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use

    • Most Recent Events

    • 21 Sep 2021 Results (n=108) of an ancillary analysis evaluating of serum mid-infrared spectroscopy as new prognostic marker for bevacizumab, presented at the 46th European Society for Medical Oncology Congress
    • 01 Nov 2016 Results of ancillary study (n=130) assessing bevacizumab pharmacokinetics using a two-compartment pharmacokinetic population model, published in the Clinical Pharmacokinetics Journal.
    • 16 Jun 2016 Results of two-compartment pharmacokinetic population model (n=130) published in the Clinical Pharmacokinetics.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top